![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: A4GALT |
Gene summary for A4GALT |
![]() |
Gene information | Species | Human | Gene symbol | A4GALT | Gene ID | 53947 |
Gene name | alpha 1,4-galactosyltransferase (P blood group) | |
Gene Alias | A14GALT | |
Cytomap | 22q13.2 | |
Gene Type | protein-coding | GO ID | GO:0001575 | UniProtAcc | A0A0S2Z5J1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
53947 | A4GALT | LZE4T | Human | Esophagus | ESCC | 3.57e-04 | 1.05e-01 | 0.0811 |
53947 | A4GALT | LZE5T | Human | Esophagus | ESCC | 7.40e-09 | 7.31e-01 | 0.0514 |
53947 | A4GALT | LZE7T | Human | Esophagus | ESCC | 1.34e-05 | 3.99e-01 | 0.0667 |
53947 | A4GALT | LZE8T | Human | Esophagus | ESCC | 9.83e-09 | 3.39e-01 | 0.067 |
53947 | A4GALT | LZE20T | Human | Esophagus | ESCC | 7.16e-06 | 2.75e-01 | 0.0662 |
53947 | A4GALT | LZE22T | Human | Esophagus | ESCC | 4.16e-05 | 4.91e-01 | 0.068 |
53947 | A4GALT | LZE24T | Human | Esophagus | ESCC | 4.95e-32 | 1.01e+00 | 0.0596 |
53947 | A4GALT | LZE21T | Human | Esophagus | ESCC | 3.12e-08 | 9.25e-01 | 0.0655 |
53947 | A4GALT | P1T-E | Human | Esophagus | ESCC | 2.56e-11 | 6.90e-01 | 0.0875 |
53947 | A4GALT | P2T-E | Human | Esophagus | ESCC | 4.69e-04 | 1.70e-01 | 0.1177 |
53947 | A4GALT | P4T-E | Human | Esophagus | ESCC | 1.28e-12 | 4.29e-01 | 0.1323 |
53947 | A4GALT | P5T-E | Human | Esophagus | ESCC | 5.30e-37 | 7.45e-01 | 0.1327 |
53947 | A4GALT | P8T-E | Human | Esophagus | ESCC | 3.41e-34 | 6.82e-01 | 0.0889 |
53947 | A4GALT | P9T-E | Human | Esophagus | ESCC | 3.64e-55 | 1.17e+00 | 0.1131 |
53947 | A4GALT | P11T-E | Human | Esophagus | ESCC | 8.13e-06 | 3.55e-01 | 0.1426 |
53947 | A4GALT | P12T-E | Human | Esophagus | ESCC | 1.41e-49 | 1.45e+00 | 0.1122 |
53947 | A4GALT | P15T-E | Human | Esophagus | ESCC | 2.76e-18 | 5.61e-01 | 0.1149 |
53947 | A4GALT | P17T-E | Human | Esophagus | ESCC | 7.59e-07 | 4.49e-01 | 0.1278 |
53947 | A4GALT | P20T-E | Human | Esophagus | ESCC | 4.66e-22 | 5.97e-01 | 0.1124 |
53947 | A4GALT | P21T-E | Human | Esophagus | ESCC | 3.05e-24 | 5.53e-01 | 0.1617 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00066433 | Esophagus | ESCC | membrane lipid metabolic process | 130/8552 | 203/18723 | 9.29e-08 | 1.54e-06 | 130 |
GO:00464673 | Esophagus | ESCC | membrane lipid biosynthetic process | 91/8552 | 142/18723 | 7.19e-06 | 7.19e-05 | 91 |
GO:00066652 | Esophagus | ESCC | sphingolipid metabolic process | 96/8552 | 155/18723 | 3.21e-05 | 2.66e-04 | 96 |
GO:00066642 | Esophagus | ESCC | glycolipid metabolic process | 63/8552 | 100/18723 | 3.55e-04 | 2.06e-03 | 63 |
GO:19035092 | Esophagus | ESCC | liposaccharide metabolic process | 63/8552 | 101/18723 | 5.25e-04 | 2.90e-03 | 63 |
GO:00301481 | Esophagus | ESCC | sphingolipid biosynthetic process | 62/8552 | 103/18723 | 2.10e-03 | 9.38e-03 | 62 |
GO:0009247 | Esophagus | ESCC | glycolipid biosynthetic process | 42/8552 | 68/18723 | 5.48e-03 | 2.05e-02 | 42 |
GO:00066432 | Oral cavity | OSCC | membrane lipid metabolic process | 111/7305 | 203/18723 | 4.02e-06 | 4.69e-05 | 111 |
GO:00066651 | Oral cavity | OSCC | sphingolipid metabolic process | 84/7305 | 155/18723 | 8.64e-05 | 6.61e-04 | 84 |
GO:00464672 | Oral cavity | OSCC | membrane lipid biosynthetic process | 77/7305 | 142/18723 | 1.63e-04 | 1.13e-03 | 77 |
GO:00066641 | Oral cavity | OSCC | glycolipid metabolic process | 53/7305 | 100/18723 | 3.09e-03 | 1.33e-02 | 53 |
GO:19035091 | Oral cavity | OSCC | liposaccharide metabolic process | 53/7305 | 101/18723 | 4.06e-03 | 1.66e-02 | 53 |
GO:0030148 | Oral cavity | OSCC | sphingolipid biosynthetic process | 53/7305 | 103/18723 | 6.81e-03 | 2.53e-02 | 53 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
A4GALT | SNV | Missense_Mutation | rs754861621 | c.1034N>T | p.Thr345Met | p.T345M | Q9NPC4 | protein_coding | deleterious(0.01) | probably_damaging(0.99) | TCGA-NH-A6GC-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Chemotherapy | fluorouracil | SD |
A4GALT | deletion | Frame_Shift_Del | c.201delN | p.Thr68ProfsTer46 | p.T68Pfs*46 | Q9NPC4 | protein_coding | TCGA-AA-A022-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
A4GALT | deletion | Frame_Shift_Del | c.201delN | p.Thr68ProfsTer46 | p.T68Pfs*46 | Q9NPC4 | protein_coding | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |||
A4GALT | SNV | Missense_Mutation | novel | c.712N>A | p.Val238Met | p.V238M | Q9NPC4 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
A4GALT | SNV | Missense_Mutation | rs370246921 | c.328G>A | p.Val110Met | p.V110M | Q9NPC4 | protein_coding | deleterious(0) | probably_damaging(0.938) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
A4GALT | SNV | Missense_Mutation | c.319G>A | p.Glu107Lys | p.E107K | Q9NPC4 | protein_coding | tolerated(0.26) | benign(0.284) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
A4GALT | SNV | Missense_Mutation | novel | c.381N>A | p.His127Gln | p.H127Q | Q9NPC4 | protein_coding | tolerated(0.06) | possibly_damaging(0.533) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
A4GALT | SNV | Missense_Mutation | c.777N>T | p.Lys259Asn | p.K259N | Q9NPC4 | protein_coding | deleterious(0.02) | possibly_damaging(0.905) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
A4GALT | SNV | Missense_Mutation | novel | c.235N>C | p.Ile79Leu | p.I79L | Q9NPC4 | protein_coding | deleterious(0.01) | benign(0.22) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
A4GALT | SNV | Missense_Mutation | novel | c.929N>T | p.Ala310Val | p.A310V | Q9NPC4 | protein_coding | tolerated(0.06) | possibly_damaging(0.533) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |